Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Diamorphine Hydrochloride Nasal Spray in Children with Acute Pain
2009-014982-16Phase 2Terminated
- Sponsor
- Wockhardt
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of diamorphine in acute pain, sponsored by Wockhardt. Primary endpoint: Safety from dosing to discharge. Started Mar 2010; status: terminated.
02
Drugs
diamorphine
03
Conditions
acute pain
Beyond the preview
Go deeper on 2009-014982-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014982-16.